Silzone-coated St. Jude medical valves: Six-year experience in 46 patients

Journal of Heart Valve Disease

Volumn 16, Issue 1, 2007, Pages 37-41

  Dandekar, Uday P ^a,b   Baghai, Max ^a   Kalkat, Maninder ^a   Ridley, Paul D ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILVER DERIVATIVE; WARFARIN;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BIOMEDICAL TECHNOLOGY ASSESSMENT; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLETE HEART BLOCK; DISEASE CLASSIFICATION; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HUMAN; MALE; MATERIAL COATING; MITRAL VALVE REPLACEMENT; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSTHESIS INFECTION; SAINT JUDE HEART VALVE PROSTHESIS; SURGICAL MORTALITY; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; ENDOCARDITIS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 33846919175     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation 1984;69:223-232
2. Agnihotri AK, McGiffin DC, Galbraith AJ, O'Brien MF. The prevalence of infective endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:1708-1720
3. Illingworth BL, Tweden K, Schroeder RF, Cameron JD. In vivo efficacy of silver-coated (Silzone) infection-resistant polyester fabric against biofilm-producing bacteria, Staphylococcus epidermidis. J Heart Valve Dis 1998;7:524-530
4. Grier N. Silver and its compounds. In: Block SS (ed.), Disinfection, sterilization and preservation. 2nd edn. Lea & Febiger, Philadelphia, 1997:395-407
5. Schaff H, Carrel T, Steckelberg JM, Grunkemeier GL, Holubkov R. Artificial Valve Endocarditis Reduction Trial (AVERT): Protocol of a multicenter randomized trial. J Heart Valve Dis 1999;8:131-139
6. Schaff HV, Carrel TP, Jamieson WRE, et al. Paravalvular leak and other events in Silzone-coated mechanical heart valves: A report from AVERT. Ann Thorac Surg 2002;73:785-792
7. Ionescu AA, Fraser AG, Butchart EG. High incidence of embolism after St. Jude Silzone prosthetic valve implantation. Circulation 1999;100(Suppl.1): 1524-1532
8. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Craig Miller D, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1996;112:708-711
9. Bodnar E. The Silzone dilemma - what did we learn? J Heart Valve Dis 2000;9:170-173
10. Grunkemeier GL, YingXing Wu. The Silzone effect: How to reconcile contradictory reports? Eur J Cardiothorac Surg 2004;25:371-375
11. Hortstkotte D, Bergemann R. Thrombogenicity of the St. Jude Medical prosthesis with and without Silzone-coated sewing cuffs. Ann Thorac Surg 2001;71:1065
12. Ionescu A, Payne N, Fraser AG, Giddings J, Grunkemeier GL, Butchart EG. Incidence of embolism and paravalvular leak after St. Jude Silzone valve implantation: Experience from the Cardiff Embolic Risk Factor Study. Heart 2003;89:1055-1061
13. Houel R, Kirsch M, Hillion ML, Loisance DY. Silzone-coated St Jude Medical valve: A safe valve. J Heart Valve Dis 2001;10:724-727
14. Auer JW, Berent R, Choi-Keung NG, et al. Early investigation of silver-coated Silzone heart valve prosthesis in 126 patients. J Heart Valve Dis 2001;10:717-723
15. Herijgers P, Herregods M-C, Vandeplas A, Meyns B, Flameng W. Silzone coating and paravalvular leak: An independent randomized study. J Heart Valve Dis 2001;10:712-716
16. Stalenhoef JE, Mellema EC, Veeger NJ, Ebels T. Thrombogenicity and reoperation of the St. Jude Medical Silzone valve: A comparison with the conventional St. Jude Medical valve. J Heart Valve Dis 2003:12:635-639
17. Ovens L, Lainchbury J, Frizelle FA, Singh H. Letter to the editor. J Heart Valve Dis 2004;13:870-871
18. Davila-Roman VG, Waggoner AD, Kennard ED, et al. Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiographic study. J Am Coll Cardiol 2004;44:1467-1472
19. Engelberger L, Carrel T, Schaff HV, Kennard ED, Holubkov R, and the AVERT Investigators. Differences in heart valve procedures between North American and European centres: A report from the Artificial Valve Endocarditis Reduction Trial (AVERT). J Heart Valve Dis 2001;10:562-571
20. Englberger L, Schaff HV, Jamieson EWR, et al. for the AVERT Investigators. Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: A report from the Artificial Valve Endocarditis Reduction Trial (AVERT). Eur J Cardiothorac Surg 2005;28:838-843
21. Cooper MH, Onsager DR, Ende D, Chopra PS. Prosthetic valve endocarditis occurring on a Silzone'-coated heart valve used as treatment for rheumatic mitral valve disease. Eur J Cardiothorac Surg 2002;21:158-159
22. Kjaergard HK, Tingleff J, Abildgaard U, Pettersson G. Recurrent endocarditis in silver-coated heart valve prosthesis. J Heart Valve Dis 1999;8:140-142
23. Ikonomidis JS, Kratz JM, Crumbley AJ, III, et al. Twenty-year experience with the St. Jude Medical mechanical valve prosthesis. J Thorac Cardiovasc Surg 2003;126:2022-2031
24. Seipelt RG, Vazquez-Jimenez JF, Seipelt IM, et al. The St. Jude Silzone valve: Midterm results in treatment of active endocarditis. Ann Thorac Surg 2001;72:758-762
25. Garcia Fuster R, Montero Argudo JA, Gil Albarova O, Hornero Sos F, Canovas S, Dalmau Sorli MJ. Employment of St. Jude 'Silzone' valve in the surgical treatment of early prosthetic valve endocarditis: A preliminary case report and review of literature. Rev Esp Cardiol 2000;53:139-141
26. Carrel T, Nguyen T, Kipfer B, et al. Definitive cure of recurrent prosthetic endocarditis using silver-coated St. Jude Medical heart valves: A preliminary case report. J Heart Valve Dis 1998;7:531-533